Is GW Pharmaceuticals plc (GWPH)’s Fuel Running High? The Stock Formed Bullish Multiple Top Pattern

April 23, 2018 - By Marie Mckinney

The stock of GW Pharmaceuticals plc (GWPH) shows a multiple tops pattern with $143.10 target or 8.00 % above today’s $132.50 share price. The 6 months chart pattern indicates low risk for the $3.74B company. It was reported on Apr, 23 by Finviz.com. If the $143.10 price target is reached, the company will be worth $298.96M more.
Multiple tops are chart patterns with decent performance in a bull market. The failure rate is higher but the average decline is reasonable. Back-tests of such patterns show that the break even failure rate is 10%, the average rise: 19%, the throwback rate: 61% and the percentage of stocks meeting their price targets: 40%.

The stock increased 0.05% or $0.07 during the last trading session, reaching $132.5. About 85,369 shares traded. GW Pharmaceuticals plc (NASDAQ:GWPH) has declined 9.18% since April 23, 2017 and is downtrending. It has underperformed by 20.73% the S&P500.

Analysts await GW Pharmaceuticals plc (NASDAQ:GWPH) to report earnings on May, 8. They expect $-2.28 earnings per share, down 34.12 % or $0.58 from last year’s $-1.7 per share. After $-2.43 actual earnings per share reported by GW Pharmaceuticals plc for the previous quarter, Wall Street now forecasts -6.17 % EPS growth.

GW Pharmaceuticals plc (NASDAQ:GWPH) Ratings Coverage

Among 5 analysts covering GW Pharma (NASDAQ:GWPH), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. GW Pharma had 11 analyst reports since October 26, 2017 according to SRatingsIntel. The firm has “Buy” rating given on Monday, December 4 by Cantor Fitzgerald. Leerink Swann maintained GW Pharmaceuticals plc (NASDAQ:GWPH) on Thursday, December 28 with “Buy” rating. As per Tuesday, November 14, the company rating was maintained by Bank of America. Leerink Swann maintained GW Pharmaceuticals plc (NASDAQ:GWPH) rating on Tuesday, January 23. Leerink Swann has “Buy” rating and $153.0 target. Cowen & Co maintained the stock with “Buy” rating in Thursday, October 26 report. Cowen & Co maintained the shares of GWPH in report on Wednesday, April 18 with “Buy” rating. The rating was maintained by Leerink Swann with “Outperform” on Tuesday, February 6. The firm has “Buy” rating given on Tuesday, April 17 by Cantor Fitzgerald. The firm has “Buy” rating by Bank of America given on Tuesday, February 6. The firm has “Buy” rating by Goldman Sachs given on Thursday, December 14.

GW Pharmaceuticals plc (NASDAQ:GWPH) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: